No Shortage of Hepatitis C Treatments

In 2011, the FDA approved Victrelis (boceprevir) to be given with peginterferon alfa and ribavirin in adult patients with liver problems who had not been previously treated or who had not responded to treatment. This medication comes in capsule form and is usually taken three times daily, with a meal or snack. Common side effects of Victrelis include tiredness, nausea and headache.